TRPV4 targeting i-body (AdAlta)

N/A

Report date: 2025/03/20 09:41:03

Base Information

Drug NameTRPV4 targeting i-body (AdAlta)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 4 modulators
TargetsTransient receptor potential cation channel subfamily V member 4
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdAlta Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdAlta Pty Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A